MBL77 SECRETS

Not all clients with CLL call for therapy. Inspite of all the latest advances, the iwCLL nevertheless recommends watchful observation for people with asymptomatic condition.86 This suggestion is based on no less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Par